<< Read Full Article
<< Read Full Article
Genentech Profit Rises on Strong Sales
Genentech's(DNA Quote) profit rose in the third quarter on increased sales of its leading cancer drugs.
Shares closed down $2.06, or 2.5%, at $79.12 in regular trading Tuesday, and were off by another 7 cents, or 0.1%, in recent post-market trading.
On a GAAP basis, the company earned $731 million, or 68 cents a share, compared with $685 million, or 64 cents a share in the comparable 2007 period. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,328.89 | 1,102.47 | 2,211.69 | 35.46 |
Oil *
73.88
|
|
UP
20.63
|
UP
6.40
|
UP
31.64
|
UP
0.59
|
10 Yr
3.55%
SPDR Gold
108.95
|
|
+0.20%
|
+0.58%
|
+1.45%
|
+1.69%
|
Data delayed 20 minutes |
Connect with TheStreet